A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Asha Das, MD
Tocagen Inc.
Study Director - Manish Aghi, MD, NS
University of California, San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Ucla
Los Angeles, California, United States
- Ucsd
San Diego, California, United States
- Ucsf
San Francisco, California, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- the Methodist Hospital Research Institute
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2010
- Primary completion
- 18 Aug 2016
- Completion
- 18 Aug 2016
- Last update posted
- 21 May 2018
- Registered enrollment
- 54
- Registry id
- NCT01156584
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.